Ancora Equity Fund


Objective & Share Information

The Ancora Equity Fund's primary objective is obtaining a high total return, a combination of income and capital appreciation in the value of its shares.

Symbol Share Class Expense Ratio Minimum* Maximum Sales Charge
ANQIX I Share 1.84% $5,000 -
ANQCX C Share 2.59% $5,000 -

*See the prospectus for minimum purchase eligibility requirements.  

Philosophy & Process

The Ancora Equity Fund pursues its investment objective by investing in publicly traded equity securities such as common stock, preferred stock and securities convertible into common or preferred stock. Under normal circumstances, at least 80% of the assets of the Fund will be invested in equity securities. The Fund emphasizes a blended value and growth style of investing. The Fund intends to invest primarily in companies that are leaders in their industries or have products and services that are dominant in the marketplace. Under normal circumstances, at least 80% of the assets of the Fund will be invested in equity securities of companies that have market capitalizations of $5 billion or more.

Performance as of 3/31/15

  Q1 YTD 1 Yr. 3 Yrs. 5 Yrs. Since Incep. (1/5/04)
Ancora Equity Fund (ANQIX) -1.51% -1.51% 3.92% 11.75% 9.37% 6.52%
Ancora Equity Fund (ANQCX) -1.74% -1.74% 3.09% 10.98% 8.70% 6.02%
S&P 500 Index 0.96% 0.96% 12.75% 16.12% 14.47% 7.99%

Performance quoted represents past performance and is not a guarantee or a reliable indicator of future results. Investment return and the principal value of an investment will fluctuate. Shares may be worth more or less than original cost when redeemed. Current performance may be lower or higher than average annual returns shown. A Redemption Fee of 2% may be assessed on shares held less than 90 days. The performance data presented does not reflect the deduction of this fee and if reflected would reduce the performance returns.

Top Ten Holdings as of 3/31/15

  Description Symbol % Weight  
1 Tri Continental Corp. TY 7.98%  
2 Boulder Growth & Income Fund, Inc. BIF 7.73%  
3 Ameriprise Financial, Inc. AMP 5.16%  
4 Parker Hannifin Corp. PH 4.68%  
5 Celgene Corp. CELG 4.55%  
6 EMC Corp. Massachusetts EMC 4.03%  
7 JP Morgan Chase & Co. JPM 3.98%  
8 General Electric Co. GE 3.91%  
9 AbbVie, Inc. ABBV 3.85%  
10 Thermo Fisher Scientific, Inc. TMO 3.53%  
  Cash   5.26%  

Purchase Availability 

  • Direct Application (click here)
  • Pershing LLC
  • Charles Schwab
  • TD Ameritrade
  • Fidelity
  • National Financial Services

Additional Purchase Information: Dan Hyland, Managing Director, Marketing & Client Services,, 216-825-4000


Investors should consider the investment objectives, risks, charges and expenses of the funds carefully before investing. This and other information are contained in the fund’s prospectus and summary prospectus, if available, which may be obtained by contacting your Ancora representative, financial advisor or by clicking here.


Large Companies. Larger, more established companies tend to operate in mature markets, which often are very competitive. Larger companies also do not tend to respond quickly to competitive changes caused by technology or consumer preferences.

Small and Mid-Cap Companies. The principal risks of investing in the Fund include the risks of investing in equity securities. The prices of equity securities fluctuate based on changes in a company’s activities and financial condition and in overall market and financial conditions. The small and mid cap companies in which the Fund invests are especially sensitive to these factors and therefore may be subject to greater share price fluctuations than other companies. Also, securities of these companies are often less liquid, thus possibly limiting the ability of the Fund to dispose of such securities when the Advisor deems it advisable to do so. As a result of these factors, securities of these small and mid cap companies may expose shareholders of the Fund to above average risk.

Closed-End Funds. The shares of many closed-end funds frequently trade at a price per share which is less than the net asset value per share, the difference representing the “market discount” of such shares. The Fund purchases shares of closed-end funds which trade at a market discount. However, there can be no assurance that the market discount on shares of any closed-end fund will ever decrease. In fact, it is possible that this market discount may increase and the Fund may suffer capital losses due to further decline in the market price of the securities of such closed-end funds, thereby adversely affecting the net asset value of the Fund’s shares.

The closed-end funds in which the Fund invests typically pay an advisory fee for the management of their portfolios, as well as other expenses. Therefore, the investment by the Fund in closed-end funds often results in a duplication of advisory fees and other expenses, thereby resulting in a lower return for the Fund than would be the case in the absence of such duplication.